Shimizu Ikuo, Ichikawa Naoaki, Yotsumoto Mihoko, Sumi Masahiko, Ueno Mayumi, Kobayashi Hikaru
Department of Hematology, Nagano Red Cross Hospital.
Rinsho Ketsueki. 2008 Jun;49(6):413-6.
A 72-year-old male presented with oral bleeding resulting from acquired factor V (FV) inhibitor. We observed abnormalities in prothrombin time (PT) (8%) and activated partial thromboplastin time (APTT) (>200 seconds). FV activity was less than 3%, and a mixing test did not correlate with PT. FV inhibitor assay demonstrated 240 Bethesda units/ml. The patient also showed markedly decreased activity of Factors II (13%) and X (14%). Oral bleeding disappeared and coagulation abnormalities improved with prednisolone therapy. High titer FV inhibitor might affect coagulation assays even in a patient with normal factor activity.
一名72岁男性因获得性凝血因子V(FV)抑制物导致口腔出血。我们观察到凝血酶原时间(PT)异常(8%)和活化部分凝血活酶时间(APTT)异常(>200秒)。FV活性低于3%,且混合试验与PT不相关。FV抑制物检测显示为240贝塞斯达单位/毫升。该患者还表现出凝血因子II(13%)和X(14%)的活性显著降低。口服泼尼松龙治疗后口腔出血消失,凝血异常得到改善。即使在因子活性正常的患者中,高滴度FV抑制物也可能影响凝血检测。